“Here you are, you need a heart — that’s a tough road for any person,” he said. “And then for that person to have to be a fundraiser?” JoNel Aleccia, Kaiser Health News When Patrick Mannion heard about the Michigan woman denied a heart transplant […]
Since the beginning of last year, 34 lawmakers have each received more than $100,000 from pharmaceutical companies. Two of those — Reps. Greg Walden of Oregon, a key Republican committee chairman, and Kevin McCarthy of California, the House Republican majority leader — each received more […]
A growing number of small-business owners say that controlling health care costs is a top priority, and it is the number one policy that they have contacted their elected officials about, a new study showed. According to the National Small Business Association’s annual Politics of […]
Promises by the pharmaceutical industry to contain prices are a familiar — and fleeting — phenomenon, say analysts who have watched the unstoppable rise in drug costs over the years. Jay Hancock, Kaiser Health News and Sarah Jane Tribble, Kaiser Health News Prescription drug prices […]
By delaying development of generics, drugmakers can maintain their monopolies and keep prices high. Most of the drugs cost Medicare Part D more in 2016 than they did in 2012, for an average spending increase of about 60 percent more per unit. This excludes drugs […]
Seniors are getting financially drained by excessive prescription drug price increases, and a congressional report released this week shows that the situation is unlikely to change anytime soon without fundamental change. The report, “Manufactured Crisis: How devastating drug price increases are harming America’s seniors,” exposed […]
This high-profile legal fight caught the attention of employers and policymakers across the country amid growing alarm about the financial implications of industry consolidation. Large health systems are gaining market clout and the ability to raise prices by acquiring more hospitals, outpatient surgery centers and […]
